✉news HealthMedicine first seen 3 h ago, last just now, peak #1
Single CRISPR treatment halves bad cholesterol for a year
Original: One CRISPR treatment cut “bad” cholesterol in half for a full year
A one-time CRISPR gene-editing treatment reduced LDL, the so-called bad cholesterol, by about half, with the effect lasting a full year, according to a study reported by ScienceDaily. The result points to durable cholesterol control from a single infusion rather than daily medication, and is drawing attention as a potential new approach to preventing heart disease.
Why now: The prospect of permanently lowering cholesterol with one gene-editing treatment is a major medical breakthrough.
Rank over time, top of the chart is #1. 5 snapshots from 3 h ago to just now.
Evidence
- One CRISPR treatment cut “bad” cholesterol in half for a full year · sciencedaily.com
- One CRISPR treatment cut “bad” cholesterol in half for a full year · ScienceDaily
API: https://socialmediatrends-api.osmike.com/v1/trends/115633